Search Results - "Regelink, Josien C."

Refine Results
  1. 1
  2. 2

    18F‐fluoro‐deoxyglucose positron emission tomography in assessment of myeloma‐related bone disease: A systematic review by van Lammeren‐Venema, Danielle, Regelink, Josien C., Riphagen, Ingrid I., Zweegman, Sonja, Hoekstra, Otto S., Zijlstra, Josée M.

    Published in Cancer (15-04-2012)
    “…BACKGROUND: The goal of this study was to conduct a comparative analysis of whole body X‐ray (WBXR) and 18F‐fluoro‐deoxyglucose positron emission tomography…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT by Adams, Hugo J. A., de Klerk, John M. H., Regelink, Josien C., Heggelman, Ben G. F., Dubois, Stefan V., Kwee, Thomas C.

    Published in Nuclear medicine and molecular imaging (01-12-2017)
    “…A 22-year-old woman was diagnosed with intermediate risk stage II Hodgkin lymphoma and treated with three cycles of adriamycin, bleomycin, vinblastine, and…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review by van Lammeren-Venema, Danielle, Regelink, Josien C, Riphagen, Ingrid I, Zweegman, Sonja, Hoekstra, Otto S, Zijlstra, Josée M

    Published in Cancer (15-04-2012)
    “…The goal of this study was to conduct a comparative analysis of whole body X-ray (WBXR) and (18) F-fluoro-deoxyglucose positron emission tomography ((18) FDG…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Cold case: COVID-19-triggered type 1 cryoglobulinemia by van Gils, L.A.J. (Luuk), Corsten, M.F. (Maarten), Koelman, C.A. (Carin), Bosma, R.J. (Renate), Fijnheer, R. (Rob), Mulder, A.H.L. (Leontine), Regelink, J.C. (Josien)

    Published in Annals of hematology (01-10-2024)
    “…A 42-year-old male was referred to the internal medicine department because of renal failure and persistent malaise after a recent SARS-CoV-2 infection. Blood…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Quantitative in-Vivo Monitoring of Bone Formation in Multiple Myeloma Patients Following Treatment with Bortezomib: A Pilot Study by Regelink, Josien C, Raijmakers, Pieter G, Bravenboer, Nathalie, Hoetjes, Nikie, Lips, Paul, Zweegman, Sonja

    Published in Blood (18-11-2011)
    “…Abstract 2939 Continuous suppression of bone formation, even after treatment, is a major concern in multiple myeloma (MM) patients. The proteasome inhibitor…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20